Lataa...
Aplastic anemia secondary to nivolumab and ipilimumab in a patient with metastatic melanoma: a case report
BACKGROUND: Immune checkpoint blockade (ICB) is becoming an increasingly prevalent strategy in the clinical realm of cancer therapeutics. With more patients being administered ICB for a host of tumor types, the scope of adverse events associated with these drugs will likely grow. Here we report a ca...
Tallennettuna:
| Julkaisussa: | Exp Hematol Oncol |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5859826/ https://ncbi.nlm.nih.gov/pubmed/29568696 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40164-018-0098-5 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|